Skip to main navigation ABOUT US TECHNOLOGY PIPELINE INVESTORS CAREERS INVESTORS CORPORATE PROFILE Morphic Therapeutic is leading the development of a new generation of oral integrin drugs, informed by decades of world-leading expertise and a unique integrin discovery platform. Morphic believes oral drugs targeting the integrin protein family can transform the treatment paradigm for patients suffering from serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, as well as fibrosis and cancer. Data Provided by Refinitiv. Minimum 15 minutes delayed. EVENTS JEFFERIES LONDON HEALTHCARE CONFERENCE Nov 17, 2021 at 1:40 PM GMT JEFFERIES IBD THERAPEUTICS SUMMIT Oct 19, 2021 at 3:15 PM EDT MORGAN STANLEY 19TH ANNUAL GLOBAL HEALTHCARE CONFERENCE Sep 10, 2021 at 12:30 PM EDT View All PRESENTATIONS Morphic Corporate Presentation November 2021 SITC AVB8 Presentation MORF-057 Phase 1 ECCO ePoster #306 MORF-57 Non-clinical ePoster #037 April 2021 AACR AVB8 Presentation October 2020 UEG Presentation June 2020 DDW A4B7 IBD Presentation February 2020 ECCO A4B7 IBD Presentation PRESS RELEASES MORPHIC ANNOUNCES PARTICIPATION IN UPCOMING INVESTOR CONFERENCES Nov 16, 2021 MORPHIC PRESENTS PRECLINICAL DATA FROM ΑVΒ8 INTEGRIN PROGRAM AT THE SITC ANNUAL MEETING Nov 15, 2021 MORPHIC ANNOUNCES CORPORATE HIGHLIGHTS AND THIRD QUARTER 2021 FINANCIAL RESULTS Nov 04, 2021 View All 35 Gatehouse Drive, A2 Waltham, MA 02451 (781) 996-0955 info@morphictx.com © 2021 Morphic Therapeutic Privacy Statement | Terms of Service

Skip to main navigation ABOUT US TECHNOLOGY PIPELINE INVESTORS CAREERS SEC FILINGS Group Filing year - Any - FILING DATE FORM DESCRIPTION Nov 04, 2021 8-K Report of unscheduled material events or corporate event Nov 04, 2021 10-Q Quarterly report which provides a continuing view of a company's financial position Nov 03, 2021 4 Statement of changes in beneficial ownership of securities Nov 03, 2021 4 Statement of changes in beneficial ownership of securities Nov 03, 2021 4/A Amendment to a previously filed 4 Nov 01, 2021 SC 13D/A An amendment to a SC 13D filing Oct 28, 2021 4 Statement of changes in beneficial ownership of securities Oct 21, 2021 4 Statement of changes in beneficial ownership of securities Oct 15, 2021 4 Statement of changes in beneficial ownership of securities Sep 17, 2021 4 Statement of changes in beneficial ownership of securities PAGINATION Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last » Data provided by Kaleidoscope. 35 Gatehouse Drive, A2 Waltham, MA 02451 (781) 996-0955 info@morphictx.com © 2021 Morphic Therapeutic Privacy Statement | Terms of Service